-
Mashup Score: 0Amyloidosis Forum 2023: ATTR Drug Development - 9 month(s) ago
Recorded and edited interviews for the “Patient Perspectives: Today’s Unmet Need” session at the 2023 Amyloidosis Forum meeting.
Source: YouTubeCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Advancing ATTR Drug Development - 9 month(s) ago
The first generation of drug approvals in #ATTR #amyloidosis has reshaped the research landscape. This month’s hybrid #AmyloidosisForum will consider how to effectively design trials against a backdrop of treatments that slow progression of the disease.
Source: The Amyloidosis ForumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Welcome! You are invited to join a webinar: Amyloidosis Forum: Advancing Drug Development in ATTR in an Evolving Treatment Landscape. After registering, you will receive a confirmation email about joining the webinar.
Source: ZoomCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6
Welcome! You are invited to join a webinar: Amyloidosis Forum: Advancing Drug Development in ATTR in an Evolving Treatment Landscape. After registering, you will receive a confirmation email about joining the webinar.
Source: ZoomCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Advancing ATTR Drug Development - 9 month(s) ago
The first generation of drug approvals in #ATTR #amyloidosis has reshaped the research landscape. This month’s hybrid #AmyloidosisForum will consider how to effectively design trials against a backdrop of treatments that slow progression of the disease.
Source: The Amyloidosis ForumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Advancing ATTR Drug Development - 9 month(s) ago
The first generation of drug approvals in #ATTR #amyloidosis has reshaped the research landscape. This month’s hybrid #AmyloidosisForum will consider how to effectively design trials against a backdrop of treatments that slow progression of the disease.
Source: The Amyloidosis ForumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Advancing ATTR Drug Development - 9 month(s) ago
The first generation of drug approvals in #ATTR #amyloidosis has reshaped the research landscape. This month’s hybrid #AmyloidosisForum will consider how to effectively design trials against a backdrop of treatments that slow progression of the disease.
Source: The Amyloidosis ForumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3
Three men who had heart failure caused by the build-up of sticky, toxic proteins are now free of symptoms after their condition spontaneously reversed in an unprecedented case described by a team at UCL and the Royal Free Hospital.
Source: UCL NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Advancing ATTR Drug Development - 10 month(s) ago
The first generation of drug approvals in #ATTR #amyloidosis has reshaped the research landscape. This month’s hybrid #AmyloidosisForum will consider how to effectively design trials against a backdrop of treatments that slow progression of the disease.
Source: The Amyloidosis ForumCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4HRQOL instruments for clinical trials in AL amyloidosis | PROM - 11 month(s) ago
Summarizing the methods, findings, and recommendations of the health-related quality of life instruments for clinical trials in AL amyloidosis. Read more
Source: www.dovepress.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Researchers, life science companies, & other #ATTR #amyloidosis HCPs: What's really important to patients and caregivers? For the #AmyloidosisForum we worked with @MathewMaurer to ask patients how the next phase of #drugdevelopment will impact their lives https://t.co/Jp151XzO7l